ICMR Designs Kit For Omicron Detection

NEW DELHI : The Indian Council of Medical Research (ICMR) has designed a diagnostic kit for detection of Omicron variant of the coronavirus and has invited expression of interest (EoI) from in vitro diagnostics (IVD) kit manufacturers for undertaking transfer of technology for its development and commercialisation.

The ICMR-Regional Medical Research Centre, NE, Dibrugarh, has developed a novel technology — real-time RT-PCR assay for detection of Omicron (B.1.1.529) variant of SARS-CoV2 and a kit for the same.

“ICMR is the owner of the said technology, including any underlying intellectual property(ies) and commercialisation rights. ICMR is lawfully entitled to enter into any form of non-exclusive license agreements with selected manufacturer/manufacturers, including transfer of technology through suitable agreement to any other interested manufacturers,” the invitation of EoI document said.

“ICMR invites EOI through email from experienced IVD kit manufacturers for undertaking transfer of technology for development and commercialisation of SARS-CoV-2 Omicron (B.1.1.529) real time RT-PCR assay through a novel diagnostic kit,” the invitation of EoI said.

  • Related Posts

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

    Spurious cosmetic packaging factory busted in northwest Delhi

    New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Spurious cosmetic packaging factory busted in northwest Delhi

    Spurious cosmetic packaging factory busted in northwest Delhi

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    UP plans US FDA-accredited medical device testing lab

    UP plans US FDA-accredited medical device testing lab

    Patent rejected for MNC’s cancer drug, generics to follow

    Patent rejected for MNC’s cancer drug, generics to follow

    Zydus brings world’s first Nivolumab biosimilar to India

    Zydus brings world’s first Nivolumab biosimilar to India